Methods of treatment with antagonists against PD-1 and PD-L1 in combination with radiation therapy
US10092645B2 · kind B2 · utility
2Cited by
0References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 16, 2015 |
| Grant date | Oct 9, 2018 |
| Priority date | — |
| Expiry date | Jun 16, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/73
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This application provides a method of treating cancer in a patient comprising administering at least one dose of radiation therapy and at least one PD-1 and/or PD-L1 antagonist, wherein at least one PD-1 and/or PD-L1 antagonist is administered on the same day as a dose of radiation therapy or up to and including 4 days later.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.